Skip to main content
HOWL
NASDAQ Life Sciences

RA Capital Reduces Stake Below 5% in Werewolf Therapeutics

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.33
Mkt Cap
$16.542M
52W Low
$0.27
52W High
$2.38
52W Position info
22% above low
Off High info
86% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

HOWL sits 22% above its 52-week low of $0.27.

Summary

Major institutional investor RA Capital Management sold an additional $316,000 in Werewolf Therapeutics stock, reducing its stake below the 5% reporting threshold.


Key Events · Ownership and Investor Activity · HOWL

  • Significant Share Sales

    RA Capital Management sold approximately 936,543 shares for a total value of about $316,247 between June 29 and July 2, 2026.

  • Ownership Below 5% Threshold

    As a result of these sales, RA Capital Management ceased to be a beneficial owner of more than 5% of Werewolf Therapeutics' common stock as of June 30, 2026.

  • Continued Institutional Distribution

    This filing extends a recent trend of institutional investors, including RA Capital, reducing their positions in the company, with net insider sales of nearly $2 million over the last 90 days.


Analysis · HOWL · Life Sciences

RA Capital Management, a significant institutional investor, has further reduced its holdings in Werewolf Therapeutics, selling approximately $316,000 worth of shares. This latest round of sales caused the firm to drop below the 5% beneficial ownership threshold as of June 30, 2026, signaling a continued reduction in their investment in the company. This follows a pattern of distribution by institutional investors over the past 90 days.

How filings like this one have moved

In the 30 days to Sep 20, 2026, 35% of the 1044 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.27 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Aug 21, 2026, 9:12 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.9898 info
Change: -$0.0517 (-5%) info
Market Cap: $46.898M info
HOWL
Aug 21, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.9898 info
Change: -$0.0517 (-5%) info
Market Cap: $46.898M info
HOWL
Aug 21, 2026, 8:51 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.994096
Real-time Price: $0.9898 info
Change: -$0.004296 (-0.43%) info
Market Cap: $46.898M info
HOWL
Aug 21, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.7528
Real-time Price: $0.9898 info
Change: +$0.237 (+31%) info
Market Cap: $46.898M info
HOWL
Aug 20, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7418
Real-time Price: $0.9898 info
Change: +$0.248 (+33%) info
Market Cap: $46.898M info